FDA Could Release GMP Data To Prod Manufacturing Improvements
This article was originally published in The Pink Sheet Daily
Executive Summary
Batch failure and other measures commonly tracked by manufacturers could be aggregated into an industry-wide index that FDA would use to help make risk-based inspection decisions.